These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9401805)

  • 1. Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center.
    Canawati HN; el-Farra R; Seymour J; Shimashita J; Dunn D; Montgomerie JZ
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):133-8. PubMed ID: 9401805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.
    Gales AC; Gordon KA; Wilke WW; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):61-4. PubMed ID: 10744370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
    Schedletzky H; Wiedemann B; Heisig P
    J Antimicrob Chemother; 1999 May; 43 Suppl B():31-7. PubMed ID: 10382873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.
    Chaniotaki S; Giakouppi P; Tzouvelekis LS; Panagiotakos D; Kozanitou M; Petrikkos G; Avlami A; Vatopoulos AC;
    Clin Microbiol Infect; 2004 Jan; 10(1):75-8. PubMed ID: 14706091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.
    Vila J; Ruiz J; Marco F; Barcelo A; Goñi P; Giralt E; Jimenez de Anta T
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2477-9. PubMed ID: 7840592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli.
    Ruiz J; Marco F; Goñi P; Gallardo F; Mensa J; Trilla A; Jimenez de Anta T; Vila J
    J Antimicrob Chemother; 1995 Oct; 36(4):737-8. PubMed ID: 8591951
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escherichia coli cells resistant to the DNA gyrase inhibitor, ciprofloxacin, overproduce a 60 kD protein homologous to GroEL.
    Hallett P; Mehlert A; Maxwell A
    Mol Microbiol; 1990 Mar; 4(3):345-53. PubMed ID: 1972534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.
    Tankovic J; Bachoual R; Ouabdesselam S; Boudjadja A; Soussy CJ
    J Antimicrob Chemother; 1999 May; 43 Suppl B():19-23. PubMed ID: 10382871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR; Tapsall JW; White PA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.
    Cambau E; Perani E; Dib C; Petinon C; Trias J; Jarlier V
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2248-52. PubMed ID: 8619577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.
    Bachoual R; Tankovic J; Soussy CJ
    Microb Drug Resist; 1998; 4(4):271-6. PubMed ID: 9988045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
    Heisig P; Schedletzky H; Falkenstein-Paul H
    Antimicrob Agents Chemother; 1993 Apr; 37(4):696-701. PubMed ID: 8388197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.